Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Cancer|January 17, 2018
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3Jeffrey S Ross, Marwan Fakih, Siraj M Ali, et al.
The Oncologist|May 22, 2022
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung CancerKarthikeyan Murugesan, Dexter X Jin, Leah A Comment, et al.
Cancer|June 11, 2016
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapiesJeffrey S Ross, Laurie M Gay, Kai Wang, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
LINE-1 retrotransposition is a recurrent cause of <i>MET</i> exon 14 skipping in cancerJennifer A Karlow, Callan O'Connor, Radwa Sharaf, et al.
JAMA Oncology|July 17, 2015
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted TherapiesJeffrey S Ross, Kai Wang, Laurie Gay, et al.
International Journal of Cancer|August 29, 2015
The distribution of BRAF gene fusions in solid tumors and response to targeted therapyJeffrey S Ross, Kai Wang, Juliann Chmielecki, et al.
Breast Cancer Research and Treatment|February 18, 2017
Comprehensive genomic profiling of malignant phyllodes tumors of the breastSahar Nozad, Christine E Sheehan, Laurie M Gay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapiesJ S Ross, L M Gay, K Wang, et al.
JCO Precision Oncology|April 10, 2018
TMPRSS2-ERG fusions unexpectedly identified in men initially diagnosed with nonprostatic malignanciesPrimo N Lara, Andreas M Heilmann, Julia A Elvin, et al.
Frontiers in Oncology|March 6, 2024
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkersDouglas I Lin, Richard S P Huang, Ioannis Ladas, et al.
Pageof 16